Sign in

CIK 0001439725 · Non-accelerated filer<br>Smaller reporting company

BIODESIX INC

Sign in to watch
Ticker
BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203986492
Phone
303-417-0500
Business address
919 WEST DILLON ROAD, LOUISVILLE, CO, 80027
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Open-market buy Director bought 128,363 shares at an average $1.69 ($216,510)
  4. 4 Grant or award Director acquired 9,989,506 shares (grant or award)
  5. SC 13D/A Stake Beneficial Ownership Report
  6. 4 Open-market sale Chief Accounting Officer sold 559 shares at an average $1.33 ($742)
  7. 4 Open-market sale Chief Development Officer sold 1,573 shares at an average $1.33 ($2,088)
  8. 4 Open-market sale Chief Commercial Officer sold 1,699 shares at an average $1.33 ($2,256)
  9. 4 Open-market sale President & CEO sold 13,782 shares at an average $1.33 ($18,297)
  10. 4 Open-market sale CFO, Sec'y & Treasurer sold 3,577 shares at an average $1.33 ($4,749)
  11. 144 Insider Sale of Securities
  12. 4 Grant or award Director acquired 12,345 shares (grant or award)
  13. 4 Grant or award Chief Accounting Officer acquired 617 shares (grant or award)
  14. 4 Grant or award Director acquired 308,640 shares (grant or award)
  15. 4 Grant or award Chief Development Officer acquired 617 shares (grant or award)
  16. 4 Grant or award Director acquired 61,728 shares (grant or award)
  17. 4 Grant or award Chief Commercial Officer acquired 6,172 shares (grant or award)
  18. 4 Grant or award Director acquired 30,864 shares (grant or award)
  19. 4 Grant or award Director acquired 6,172,839 shares (grant or award)
  20. 4 Grant or award Director acquired 6,172 shares (grant or award)

Page 14 of 31 · 602 filings